Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Dehlin

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
RMD Open|May 25, 2021
Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western SwedenAnton Jonatan Landgren, Mats Dehlin, Lennart Jacobsson, et al.
The Journal of Rheumatology|April 3, 2019
The Validity of Gout Diagnosis in Primary Care: Results from a Patient SurveyMats Dehlin, Anton J Landgren, Ulrika Bergsten, et al.
The Journal of Rheumatology|July 17, 2019
Dr. Dehlin, <i>et al</i> replyMats Dehlin, Anton J Landgren, Ulrika Bergsten, et al.
Mediators of Inflammation|September 9, 2014
Smoking is associated with reduced leptin and neuropeptide Y levels and higher pain experience in patients with fibromyalgiaMaria I Bokarewa, Malin C Erlandsson, Jan Bjersing, et al.
Annals of the Rheumatic Diseases|November 25, 2017
Work disability in gout: a population-based case-control studyValgerdur Sigurdardottir, Panagiota Drivelegka, Anna Svärd, et al.
Arthritis Research & Therapy|July 11, 2012
Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptidesJan L Bjersing, Mats Dehlin, Malin Erlandsson, et al.
Rheumatology Advances in Practice|March 22, 2021
Impact of psoriasis disease activity and other risk factors on serum urate levels in patients with psoriasis and psoriatic arthritis-a <i>post-hoc</i> analysis of pooled data from three phase 3 trials with secukinumabMats Dehlin, Andreas E R Fasth, Maximilian Reinhardt, et al.
Arthritis Care & Research|September 12, 2022
Incident Gout and Risk of First-Time Acute Coronary Syndrome: A Prospective, Population-Based Cohort Study in SwedenPanagiota Drivelegka, Lennart T H Jacobsson, Ulf Lindström, et al.
RMD Open|July 20, 2020
Occupational exposure to inorganic dust and risk of gout: a population-based studyValgerdur Sigurdardottir, Lennart Jacobsson, Linus Schiöler, et al.
Arthritis Research & Therapy|June 2, 2018
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapyPanagiota Drivelegka, Valgerdur Sigurdardottir, Anna Svärd, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
RMD Open|May 25, 2021
Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western SwedenAnton Jonatan Landgren, Mats Dehlin, Lennart Jacobsson, et al.
The Journal of Rheumatology|April 3, 2019
The Validity of Gout Diagnosis in Primary Care: Results from a Patient SurveyMats Dehlin, Anton J Landgren, Ulrika Bergsten, et al.
The Journal of Rheumatology|July 17, 2019
Dr. Dehlin, <i>et al</i> replyMats Dehlin, Anton J Landgren, Ulrika Bergsten, et al.
Mediators of Inflammation|September 9, 2014
Smoking is associated with reduced leptin and neuropeptide Y levels and higher pain experience in patients with fibromyalgiaMaria I Bokarewa, Malin C Erlandsson, Jan Bjersing, et al.
Annals of the Rheumatic Diseases|November 25, 2017
Work disability in gout: a population-based case-control studyValgerdur Sigurdardottir, Panagiota Drivelegka, Anna Svärd, et al.
Arthritis Research & Therapy|July 11, 2012
Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptidesJan L Bjersing, Mats Dehlin, Malin Erlandsson, et al.
Rheumatology Advances in Practice|March 22, 2021
Impact of psoriasis disease activity and other risk factors on serum urate levels in patients with psoriasis and psoriatic arthritis-a <i>post-hoc</i> analysis of pooled data from three phase 3 trials with secukinumabMats Dehlin, Andreas E R Fasth, Maximilian Reinhardt, et al.
Arthritis Care & Research|September 12, 2022
Incident Gout and Risk of First-Time Acute Coronary Syndrome: A Prospective, Population-Based Cohort Study in SwedenPanagiota Drivelegka, Lennart T H Jacobsson, Ulf Lindström, et al.
RMD Open|July 20, 2020
Occupational exposure to inorganic dust and risk of gout: a population-based studyValgerdur Sigurdardottir, Lennart Jacobsson, Linus Schiöler, et al.
Arthritis Research & Therapy|June 2, 2018
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapyPanagiota Drivelegka, Valgerdur Sigurdardottir, Anna Svärd, et al.
Pageof 6